Таблица 3. Показатели антиоксидантной защиты на фоне наличия/отсутствия отдаленного метастазирования.

Indicators

HT

T1-4N0-3M0

T1-4N0-3M1

p-value

Uric acid, nmol/ml

АC

88.79
[42.34; 181.45]

56.45
[22.28; 96.53]

0.0069

SCLC

100.92
[47.03; 157.69]

98.62
[32.69; 197.50]

-

Albumin, mmol/l

АC

0.356
[0.184; 0.553]

0.295
[0.178; 0.455]

-

SCLC

0.313
[0.166; 0.500]

0.317
[0.178; 0.490]

-

Catalase, mcat/l

АC

2.82
[2.14; 4.41]

2.45
[1.86; 3.64]

0.0456

SCLC

2.70
[2.17; 2.74]

2.22
[1.86; 4.14]

0.0008

SOD, c.u.

АC

61.84
[28.95; 126.32]

60.53
[15.79; 76.32]

-

SCLC

52.63
[26.32; 92.11]

65.79
[42.11; 89.47]

-

АОА, mmol/l

АC

1.74
[1.38; 2.07]

1.77
[1.56; 2.14]

-

SCLC

1.86
[1.60; 2.18]

1.37
[1.03; 1.74]

-

Peroxidase, c.u.

АC

0.460
[0.370; 0.930]

0.500
[0.180; 0.860]

0.0354

SCLC

0.310
[0.220; 0.630]

0.530
[0.330; 0.825]

0.0001

SOD/Catalase

АC

15.21
[8.47; 28.22]

19.25
[9.34; 39.86]

-

SCLC

21.52
[8.15; 32.64]

26.27
[13.48; 48.06]

-

SOD/Peroxidase

АC

134.6
[34.2; 210.6]

101.2
[17.0; 189.5]

0.0218

SCLC

97.0
[50.1; 514.1]

84.9
[64.4; 103.5]

-

Примечание. HT- гистологический тип, AC– аденокарцинома, SCLC – плоскоклеточный рак легкого.